O. Pillet

636 total citations
24 papers, 340 citations indexed

About

O. Pillet is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medicine and Neurology. According to data from OpenAlex, O. Pillet has authored 24 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Emergency Medicine and 3 papers in Neurology. Recurrent topics in O. Pillet's work include Respiratory Support and Mechanisms (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). O. Pillet is often cited by papers focused on Respiratory Support and Mechanisms (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). O. Pillet collaborates with scholars based in France, Slovakia and United States. O. Pillet's co-authors include Y. Castaing, G. Manier, J. Moinard, N. Amoretti, Michel Le Bras, É. Monlun, Olivier Gille, F. Cornélis, Olivier Hauger and Marie‐Elise Truchetet and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

O. Pillet

21 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Pillet France 11 158 61 53 47 42 24 340
Jowita Biernawska Poland 8 95 0.6× 43 0.7× 16 0.3× 40 0.9× 36 0.9× 44 384
Anca B. Roald Norway 7 113 0.7× 71 1.2× 12 0.2× 38 0.8× 47 1.1× 8 496
M Guillot France 11 202 1.3× 32 0.5× 22 0.4× 65 1.4× 44 1.0× 29 430
C L Fields United States 10 136 0.9× 22 0.4× 16 0.3× 60 1.3× 25 0.6× 29 329
Gülşen Ekíngen Türkiye 13 106 0.7× 29 0.5× 34 0.6× 20 0.4× 48 1.1× 32 473
Lea Bentur Israel 13 200 1.3× 22 0.4× 18 0.3× 54 1.1× 38 0.9× 39 383
Brodie Parent United States 13 61 0.4× 34 0.6× 15 0.3× 31 0.7× 30 0.7× 25 383
Didem Aliefendioğlu Türkiye 12 117 0.7× 29 0.5× 17 0.3× 76 1.6× 75 1.8× 54 432
Josè Vitale Italy 12 80 0.5× 67 1.1× 21 0.4× 35 0.7× 24 0.6× 30 336
Michael A. Geheb United States 12 150 0.9× 23 0.4× 9 0.2× 43 0.9× 85 2.0× 17 454

Countries citing papers authored by O. Pillet

Since Specialization
Citations

This map shows the geographic impact of O. Pillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Pillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Pillet more than expected).

Fields of papers citing papers by O. Pillet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Pillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Pillet. The network helps show where O. Pillet may publish in the future.

Co-authorship network of co-authors of O. Pillet

This figure shows the co-authorship network connecting the top 25 collaborators of O. Pillet. A scholar is included among the top collaborators of O. Pillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Pillet. O. Pillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathis, Stéphane, et al.. (2024). Changes in Non-invasive Ventilation Compliance in Patients With Amyotrophic Lateral Sclerosis: A Post-hoc Analysis. Archivos de Bronconeumología. 61(1). 47–49.
2.
Mathis, Stéphane, et al.. (2024). Factors associated with survival after early at-home NIV initiation in ALS patients. Journal of Neurology. 271(8). 5590–5597. 2 indexed citations
3.
Enaud, Raphaël, Sébastien Imbert, O. Pillet, et al.. (2023). Lung Mycobiota α-Diversity Is Linked to Severity in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Microbiology Spectrum. 11(2). e0506222–e0506222. 5 indexed citations
4.
Mathis, Stéphane, et al.. (2022). At-home noninvasive ventilation initiation with telemonitoring in amyotrophic lateral sclerosis patients: a retrospective study. ERJ Open Research. 9(1). 438–2022. 12 indexed citations
5.
Cornélis, F., Marie‐Elise Truchetet, N. Amoretti, et al.. (2013). Bisphosphonate therapy for unresectable symptomatic benign bone tumors: A long-term prospective study of tolerance and efficacy. Bone. 58. 11–16. 65 indexed citations
6.
Labadie, Magali, et al.. (2012). Empoisonnement à l’Aldicarbe : symptomatologie des intoxications aux inhibiteurs de l’acétylcholinestérase de type carbamate. Annales françaises de médecine d’urgence. 3(1). 31–34. 1 indexed citations
7.
Blazejewski, Sylvie, Jean‐Benoît Corcuff, Abdelilah Abouelfath, et al.. (2009). The chronic oral administration of arginine aspartate decreases secretion of IGF‐1 and IGFBP‐3 in healthy volunteers. Fundamental and Clinical Pharmacology. 23(3). 339–344. 2 indexed citations
8.
Moinard, J., et al.. (2006). Peak anaerobic power in patients with COPD: gender related differences. European Journal of Applied Physiology. 97(3). 307–315. 12 indexed citations
9.
Gruson, Didier, Frédéric Vargas, Gilles Hilbert, et al.. (2004). Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia. Intensive Care Medicine. 30(5). 965–971. 20 indexed citations
10.
Pillet, O., et al.. (2004). Diminution de la fonction musculaire dynamique dans la BPCO : étude préliminaire. Revue des Maladies Respiratoires. 21(6). 1075–1081. 1 indexed citations
11.
Chauveau, Philippe, Olivier Guisset, Catherine Lasseur, et al.. (2003). Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Critical Care. 7(6). R160–6. 25 indexed citations
12.
Bonarek, M., P. Morlat, Geneviève Chêne, et al.. (2001). Prognostic score of short-term survival in HIV-infected patients admitted to medical intensive care units. International Journal of STD & AIDS. 12(4). 239–244. 14 indexed citations
13.
Bédry, R., et al.. (1999). Non-fatal clozapine (LEPONEX) intoxication with toxicokinetic evaluation.. PubMed. 41(1). 20–2. 6 indexed citations
14.
Pillet, O., G. Manier, & Y. Castaing. (1998). Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.. PubMed. 53(1). 3–8. 5 indexed citations
15.
Pillet, O. & Y. Castaing. (1997). Le rapport ventilation/perfusion pulmonaire. Réanimation Urgences. 6(1). 33–49.
16.
Moinard, J., G. Manier, O. Pillet, & Y. Castaing. (1994). Effect of Inhaled Nitric Oxide on Hemodynamics and VA/Q Inequalities in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 149(6). 1482–1487. 70 indexed citations
17.
Monlun, É., Antoine Leenhardt, O. Pillet, et al.. (1993). [Ventricular arrhythmia and halofantrine intake. Probable deleterious effect. Apropos of 3 cases].. PubMed. 86(5). 365–7; discussion 367. 11 indexed citations
18.
Pillet, O., et al.. (1993). Effects of Inspiratory Flow Rate Alterations on Gas Exchange During Mechanical Ventilation in Normal Lungs. CHEST Journal. 103(4). 1161–1165. 15 indexed citations
19.
Castot, A, Priscila Bogar Rapoport, Pierre Le Coz, et al.. (1993). Prolonged QT interval with halofantrine. The Lancet. 341(8859). 1541–1542. 55 indexed citations
20.
Pillet, O., et al.. (1992). Les crises convulsives d'origine toxique. Réanimation Urgences. 1(2). 341–347. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jowita Biernawska Breakdown of academic impact, for papers by Anca B. Roald Breakdown of academic impact, for papers by M Guillot Breakdown of academic impact, for papers by C L Fields Breakdown of academic impact, for papers by Gülşen Ekíngen Breakdown of academic impact, for papers by Lea Bentur Breakdown of academic impact, for papers by Brodie Parent Breakdown of academic impact, for papers by Didem Aliefendioğlu Breakdown of academic impact, for papers by Josè Vitale Breakdown of academic impact, for papers by Michael A. Geheb
Rankless by CCL
2026